Bizarre Patents
Mouse device with a built-in printer
A mouse device for use as an input device of a computer is provided that includes a housing in which recording paper is loadable, and a printer unit provided within the housing for printing on the recording paper print information received from the computer.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128781 | FUNCTIONALIZATION OF NANOPARTICLES BY GLUCOSAMINE DERIVATIVES The present invention relates to oligomeric or polymeric saccharide derivatives comprising glucosamine moieties, e.g. derivatives of oligomeric or polymeric glucosamines such as chitosan oligomers or polymers, in which one or more amine groups are substituted by anchori... | 05/24/2012 |
| 20120130045 | BIOMOLECULE-POLYMER CONJUGATES AND METHODS OF MAKING SAME Disclosed herein are biomolecule-polymer conjugates of Formula 1, as well as methods of preparing same and kits for preparing same. ... | 05/24/2012 |
| 20120129803 | COMPOSITION CONTAINING CHITOOLIGOSACCHARIDE FOR RECOVERING FROM FATIGUE Disclosed is an anti-fatigue composition containing chitooligosaccharide as an active ingredient. The composition exhibits a fatigue recovery effect, and thus can be widely used in the health food or medical field.... | 05/24/2012 |
| 20120129915 | ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.... | 05/24/2012 |
| 20120108540 | Preservatives from Chitin Derivatives The invention comprises a process for producing a chitosan derivative, and a product prepared thereby, by activating chitosan or a chitosan precursor chitin in alcohol that contains water from 0% to maximum of about 30% and preparing derivatives by reacting with a reage... | 05/03/2012 |
| 20120053331 | GLYCOL CHITOSAN DERIVATIVE, PREPARATION METHOD THEREOF AND DRUG DELIVERY SYSTEM COMPRISING THE SAME The present invention relates to a glycol chitosane derivative, a preparation method thereof and a drug delivery system comprising the same. More specifically, the invention relates to a glycol chitosan derivative, which can form nano-sized self-assembled structures and... | 03/01/2012 |
| 20120052042 | AMPHIPHILIC COMPOUNDS AND SELF-ASSEMBLING COMPOSITIONS MADE THEREFROM The present disclosure relates to amphiphilic compounds, self assembling compositions formed from the amphiphilic compounds and methods of making such compositions.... | 03/01/2012 |
| 20120035321 | COMPOUNDS AND MEDICAL DEVICES ACTIVATED WITH SOLVOPHOBIC LINKERS The present disclosure relates to compounds and medical devices activated with a solvophobic material functionalized with a first reactive member and methods of making such compounds and devices.... | 02/09/2012 |
| 20120027814 | Polymeric Fibers Having Tissue Reactive Members A method for bonding a polymeric fiber to tissue is provided which includes providing a polymeric fiber having a plurality of tissue reactive members linked to a surface of the fiber via a specific binding pair, and contacting the polymeric fiber to biological tissue, t... | 02/02/2012 |
| 20120029150 | CROSSLINKED FIBERS AND METHOD OF MAKING SAME BY EXTRUSION The present disclosure relates to a method of forming fibers. First and second precursors, each possessing a core and at least one functional group known to have click reactivity, are mixed. The mixed precursors are then extruded under heat to cross-link during fiber pr... | 02/02/2012 |
| 20120022242 | METHOD FOR PRODUCING AN ELONGATE POLYSACCHARIDE ELEMENT, IN PARTICULAR A CHITOSAN THREAD, AND POLYSACCCHARIDE THREAD OBTAINED The invention relates to a method for producing an elongate polysaccharide element, in particular a chitosan thread, comprising an operation of extruding an extrusible solution of said polysaccharide through an extrusion die and an operation of coagulating the extruded ... | 01/26/2012 |
| 20120020958 | FIBCD1 FOR THE PREVENTION AND TREATMENT OF DISEASES The present invention relates to methods and compositions for the treatment and/or prevention of diseases such as allergic diseases and inflammatory bowel diseases comprising one or more FIBCD1 binding molecules or pharmaceutically acceptable salts, esters, and amides t... | 01/26/2012 |
| 20120014874 | PHOTOSENSITIZER-METAL NANOPARTICLE CHARGE COMPLEX AND COMPOSITION CONTAINING THE COMPLEX FOR PHOTODYNAMIC THERAPY OR DIAGNOSIS Provided are a photosensitizer-metal nanoparticle charge complex and a composition for photodynamic therapy or diagnosis containing the same. The complex includes a metal nanoparticle, a photosensitizer charged with a first charge, and a linker bound to the metal nanopa... | 01/19/2012 |
| 20120004401 | COMPOSITIONS COMPRISING LIPOCHITOOLIGOSACCHARIDES Compositions containing lipochitooligosaccharides are disclosed. The compositions can be used to treat the roots, leaves, or seeds of plants and can be applied in the soil, to plant foliage, or as a seed coating... | 01/05/2012 |
| 20110319528 | METHOD FOR PRODUCING CHITIN NANOFIBERS, COMPOSITE MATERIAL AND COATING COMPOSITION EACH CONTAINING CHITIN NANOFIBERS, AND METHOD FOR PRODUCING CHITOSAN NANOFIBERS, COMPOSITE MATERIAL AND COATING COMPOSITION EACH CONTAINING CHITOSAN NANOFIBERS The present invention provides a method for producing chitin nanofibers, which includes the steps of deproteinizing a material derived from a chitin-containing organism by an alkali treatment, deashing a deproteinized integument by an acid treatment, optionally treating... | 12/29/2011 |
| 20110303611 | Molecularly Imprinted Polymers Disclosed is a cross-linked molecularly imprinted polymer including cross-linked chitosan having selective binding sites for phosphate ions, phosphate containing molecules, or a combination of both.... | 12/15/2011 |
| 20110297622 | TREATMENT ADDITIVES, METHODS FOR MAKING AND METHODS FOR CLARIFYING AQUEOUS MEDIA A coagulant composition includes chitosan, methacryloyloxyethyltrimethyl ammonium methyl sulfate and a redox initiator. A coagulant, method for making the coagulant and clarifying wastewater is also provided.... | 12/08/2011 |
| 20110283918 | COATINGS FROM NATURAL MACROMOLECULES, WITH GAS BARRIER PROPERTIES TAILORED IN SITU, AND RELATED PREPARATION METHOD The invention concerns lake compositions based on natural macromolecules (gelatin, chitosan, pectine etc.) with possible additions of vinyl polymers, metal-alcoxides etc., characterized by a barrier effect modulated in situ, in particular as a function of the relative h... | 11/24/2011 |
| 20110281729 | SYNTHETIC COMPOUNDS USEFUL AS NODULATION AGENTS OF LEGUMINOUS PLANTS AND PREPARATION PROCESSES THEREOF The present invention relates to synthetic compounds that are active on plants, especially as legume nodulation factors, and also as plant growth stimulators, and to methods for preparing such compounds, which are of formula (I). ... | 11/17/2011 |
| 20110280914 | HYDROGELS CROSSLINKED WITH GOLD NANOPARTICLES AND METHODS OF MAKING AND USING THEREOF Described herein are composites useful in tissue and organ engineering. In one aspect, the composite comprises the reaction product between a macromolecule comprising at least one thiol group and a gold nanoparticle. The thiolated macro-molecule crosslinks with the gold... | 11/17/2011 |
| 20110282042 | OBTAINMENT OF CHITIN FROM SHRIMP WASTE BY MEANS OF MICROWAVE AND/OR AUTOCLAVING IN COMBINATION WITH ORGANIC ACIDS IN A SINGLE STAGE This invention relates to the development of a new method of production of chitin through employment of a microwave process under pressure and/or autoclave with organic acids. This new method eliminates salts and proteins in a single stage and reduces contamination leve... | 11/17/2011 |
| 20110280929 | SIRNA OF NF-KB P105 FOR INHIBITING CELL PROLIFERATION AND MIGRATION AND A COMPOSITION COMPRISING SAME The present invention relates to a siRNA which targets mRNA of the NF-Kappa B p105 gene to cause its degradation by RNAi induction. In addition, the present invention provides a pharmaceutical composition for the treatment of diseases associated with aberrant cell proli... | 11/17/2011 |
| 20110257381 | PHARMACEUTICAL COMPOSITION COMPRISING CHITO-OLIGOMERS Compositions are provided comprising chito-oligomers obtainable from chitin, comprising oligomers of N-acetyl glucosamine (NAG) and glucosamine, wherein at least 50% of the oligomers have a chain length of about 2-50, and the degree of deacetylation of the oligomers is ... | 10/20/2011 |
| 20110223422 | POLYMERIC STRUCTURES COMPRISING A HYDROPHILE Hydroxyl polymer-containing compositions, especially hydroxyl polymer-containing compositions that can be processed into polymeric structures, especially polymeric structures in the form of fibers are provided.... | 09/15/2011 |
| 20110223259 | ANTI-VIRAL PHARMACEUTICAL COMPOSITIONS The present invention provides antiviral compositions that comprise one or more of an ionic multivalent metal component, a cationic polymer, and a cationic surfactant. The present invention also provides methods for making and using such antiviral compositions.... | 09/15/2011 |
| 20110217750 | Dendrimers and Dendrimer Applications An activatable functionalised Nth generation dendrimer having: a core comprising a first monomer having at least two carboxylic acid functional groups; and N successive generations, where N=0 to 10, wherein each generation comprises: a second monomer having a... | 09/08/2011 |
| 20110206617 | MODIFIED POLYSACCHARIDES FOR DRUG AND CONTRAST AGENT DELIVERY According to one embodiment, the disclosure provides a delivery formulation including a chitosan in which the primary amines are partially modified with 4-imidazole acetic acid monohydrochloride and a therapeutic or imaging material. According to another embodiment, the... | 08/25/2011 |
| 20110196140 | Chitosan having tropomyosin content assessed by method of determining tropomyosin in chitosan This invention provides a method capable of easily determining with high accuracy a protein in chitosan, said protein having a potential relevance to the development of an allergy, specifically tropomyosin and the content of the peptide. According to the method, tropomy... | 08/11/2011 |
| 20110190399 | CURCUMIN NANOPARTICLES AND METHODS OF PRODUCING THE SAME The present invention provides for curcumin nanoparticles and curcumin bound to chitosan nanoparticles and methods of producing the same. Bioavailability of curcumin in these formulations was shown to improve by more than 10 fold.... | 08/04/2011 |
| 20110171716 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF Provided herein are water-soluble carbohydrate polymers which are monoderivatized at their reducing terminus, such that the carbohydrate polymers can be selectively conjugated at a single location. Also provided are methods of preparation and conjugation of the monoderi... | 07/14/2011 |
| 20110142947 | NOVEL FORMULATIONS Nanoparticles comprising T3 and their use in treating, e.g., cardiac conditions, for example cardiac arrest, are provided. Such nanoparticles provide improved delivery of T3 and allow for acute treatment and optionally for sustained release of T3 in a patient.... | 06/16/2011 |
| 20110136722 | Drug Delivery Carrier The present disclosure relates to a method for the sustained release of a drug, comprising the steps of: (a) preparing a biocompatible polymer having a hydrophobic group conjugated to the biocompatible polymer; and (b) contacting the biocompatible polymer to the drug fo... | 06/09/2011 |
| 20110136255 | COMPOSITION AND METHOD FOR PREDICTION OF COMPLICATED DISEASE COURSE IN CROHN'S DISEASE Methods of identifying Crohn's disease patients who may require early surgery and/or who are susceptible to developing complications during the course of disease. Anti-laminarin (anti-L) and anti-chitin (anti-C) antibodies, both independently and combined, can serve as ... | 06/09/2011 |
| 20110129528 | SUSTAINED-RELEASE CHITOSAN CAPSULES COMPRISING CHITOSAN AND PHYTIC ACID The present invention relates to a chitosan capsule in which a soluble active ingredient is encapsulated in a matrix containing chitosan and phytic acid; a cross-linking method and materials capable of being used in preparing the capsule; and pharmaceutical, food and co... | 06/02/2011 |
| 20110130473 | DILUTE FILTRATION STERILIZATION PROCESS FOR VISCOELASTIC BIOPOLYMERS Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis, however, traditional sterilization techniques result in the breakdown of such high molecular weight viscoelastic ... | 06/02/2011 |
| 20110118364 | PHARMACEUTICAL COMPOSITIONS OF NANOPARTICLES CONTAINING ACTIVE INGREDIENTS This invention concerns a manufacturing process for nanoparticles composted of biodegradable polymers and active ingredients with therapeutic, cosmetic, veterinary, and alimentary applications, and a composition which contains said nanoparticles, which are used in produ... | 05/19/2011 |
| 20110118200 | A PEGYLATED AND FATTY ACID GRAFTED CHITOSAN OLIGOSACCHARIDE, SYNTHESIS METHOD AND APPLICATION FOR DRUG DELIVERY SYSTEM The present invention provides a PEGylated and fatty acid grafted chitosan oligosaccharide comprising a structural unit represented by the following Formula (I) and a structural unit represented by the following Formula (II) and synthesize method, wherein the chitosan o... | 05/19/2011 |
| 20110087012 | NUCLEIC ACID MOLECULES CODING FOR A PROTEIN WITH DEACETYLASE ACTIVITY, SAID PROTEIN, AND METHOD FOR THE PRODUCTION OF CHITOSAN The invention relates to nucleic acid molecules selected from the group comprising: a) nucleic acid molecules that code for a form of the polypeptide with the derived amino acid sequence according to SEQ ID No. 3, said polypeptide having a deacetylase activity; b) nucle... | 04/14/2011 |
| 20110081677 | Active Microfluidic Membranes The present invention relates to a biofabricated Active Microfluidic Membrane (AMM) in a microfluidic network of a microfluidic device and a method for the in situ biofabrication of such a microfluidic network. More specifically, the invention relates to devices exhibit... | 04/07/2011 |
| 20110082427 | BIORESORBABLE EMBOLIZATION MICROSPHERES The present disclosure is generally directed to an embolic material which, in some embodiments, may be in the form of a microsphere or a plurality of microspheres. The embolic material generally comprises carboxymethyl chitosan (CCN) crosslinked with carboxymethyl cellu... | 04/07/2011 |
